Amgen becomes 10th drugmaker to restrict 340B discounts to safety net hospitals
(By Katie Adams for Becker’s Hospital Review) Beginning Jan. 3, Amgen will curtail drug discounts to safety net hospitals’ contract
Read More
We’ll know more soon about Omicron. Here’s how to interpret the coming flood of data
(By Andrew Joseph for STAT) At some point in the next few weeks, scientists will start releasing data from lab experiments
Read MoreCommunity providers: Please tell Veterans about easy, no-cost flu shot options through VA
(Source – blogs.va.gov) With the combined risk of flu and COVID-19, this flu season comes with unique challenges for our
Read MoreCigna broadens Florida reach with new counties, expanded HCA Healthcare partnership
( By Nick Moran for Becker’s Hospital Review) Cigna is expanding its Florida Medicare Advantage offerings by stepping into two new counties
Read MoreFirst case of Omicron coronavirus variant identified in the U.S.
(By Andrew Joseph for STAT) U.S. health officials on Wednesday reported the country’s first case of the Omicron variant of the coronavirus,
Read MoreA reason for optimism on Omicron: Our immune systems are not blank slates
(By Helen Branswell for STAT) The emergence of a new Covid-19 variant with a startlingly large constellation of mutations has
Read MoreFee-for-service care could cost Medicaid $4.4T, UnitedHealth Group says
(By Nick Moran for Becker’s Hospital Review) Continuing to use fee-for-service care for Medicaid and dual-eligible recipients could cost the
Read MoreFor Older Adults, Smelling the Roses May Be More Difficult
(By Judith Graham for Kaiser Health News) The reports from covid-19 patients are disconcerting. Only a few hours before, they
Read MoreRecord-high Medicare premium increase unrelated to growing inflation, report says
(By Nick Moran for Becker’s Hospital Review) Despite the country’s decades-high 6.2 percent inflation rate in October, a Nov. 24
Read MoreNew antiviral drugs are coming for COVID. Here’s what you need to know
(By Pien Huang for NPR) An FDA advisory committee is meeting Tuesday to consider whether to recommend a new antiviral
Read More